Well-designed RCT demonstrating non-inferiority of the new anticoagulant. Bleeding risk stratification tools need updating accordingly. - https://sentibene.ch/vertriebspartner.html , This article makes a compelling case for value-based healthcare models. .
Aecssn mjliol
Well-designed RCT demonstrating non-inferiority of the new anticoagulant. Bleeding risk stratification tools need updating accordingly. - https://sentibene.ch/vertriebspartner.html , This article makes a compelling case for value-based healthcare models. .